MAM
MACK

Martingale Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Martingale Asset Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,520
Closed -$155K – 871
2024
Q1 		$155K Buy
+10,520
New +$155K ﹤0.01% 793